Skip to main content
Premium Trial:

Request an Annual Quote

Human Genome Sciences Posts Widened Loss Amid Shriveled Revenue

NEW YORK, Feb. 14 - Human Genome Sciences on Thursday said that bolstered R&D to develop new drugs together with shriveled revenue brought on by the end of the Human Gene Consortium caused net losses to widen in the fourth quarter.
 
Revenue for the period ended Dec. 31 plummeted to $642,000 from $5.3 million one year because the exclusivity of the genetic information it once licensed expired along with the Consortium, giving customers the green light to hunt for the data elsewhere.


R&D in the quarter shot up to $40.3 million compared with $26.7 in the year-ago period as the fledgling drug-development firm ramped up its effort to develop a product. This helped to drive up net loss to $55.2 million, or $.43 a share, compared with a net loss of $6 million, or a nickel a share, in the fourth quarter of 2000.

 

As of Dec. 31, HGS had about $1.7 billion in cash.

The Scan

Researchers Develop Polygenic Risk Scores for Dozens of Disease-Related Exposures

With genetic data from two large population cohorts and summary statistics from prior genome-wide association studies, researchers came up with 27 exposure polygenic risk scores in the American Journal of Human Genetics.

US Survey Data Suggests Ancestry Testing Leads Way in Awareness, Use of Genetic Testing Awareness

Although roughly three-quarters of surveyed individuals in a Genetics in Medicine study reported awareness of genetic testing, use of such tests was lower and varied with income, ancestry, and disease history.

Coral Genome Leads to Alternative Amino Acid Pathway Found in Other Non-Model Animals

An alternative cysteine biosynthesis pathway unearthed in the Acropora loripes genome subsequently turned up in sequences from non-mammalian, -nematode, or -arthropod animals, researchers report in Science Advances.

Mosquitos Genetically Modified to Prevent Malaria Spread

A gene drive approach could be used to render mosquitos unable to spread malaria, researchers report in Science Advances.